All Curated Mutation Sites in HSV2 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HSV2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
TK
  
DNA pol
  
UL52
  
UL5
  
UL30
  
UL23
  

Keyword: UL30
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 37632051 A9T
UL30
UL30
HSV-2 Infection
R
C
L
View
2 37632051 P15S
UL30
UL30
HSV-2 Infection
R
C
L
View
3 37632051 C40W
UL30
UL30
HSV-2 Infection
R
C
L
View
4 37632051 L60P
UL30
UL30
HSV-2 Infection
R
C
L
View
5 37632051 E139K
UL30
UL30
HSV-2 Infection
R
C
L
View
6 37632051 D676G
UL30
UL30
HSV-2 Infection
R
C
L
View
7 37632051 E678G
UL30
UL30
HSV-2 Infection
R
C
L
View
8 37632051 T801P
UL30
UL30
HSV-2 Infection
R
C
L
View
9 37632051 A1000T
UL30
UL30
HSV-2 Infection
R
C
L
View
10 37632051 P138H
UL30
UL30
HSV-2 Infection
R
C
L
View
11 37632051 E191K
UL30
UL30
HSV-2 Infection
R
C
L
View
12 37632051 684_685delGD
UL30
UL30
HSV-2 Infection
R
C
L
View
13 37632051 D716A
UL30
UL30
HSV-2 Infection
R
C
L
View
14 37632051 Q792R
UL30
UL30
HSV-2 Infection
R
C
L
View
15 37632051 I1033V
UL30
UL30
HSV-2 Infection
R
C
L
View
16 37632051 A1065T
UL30
UL30
HSV-2 Infection
R
C
L
View
Contents
Description

The table shows all curated mutation sites of HSV2 in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.